vs

Side-by-side financial comparison of INDEPENDENCE REALTY TRUST, INC. (IRT) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $165.3M, roughly 1.4× INDEPENDENCE REALTY TRUST, INC.). On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 2.5%). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 2.2%).

Brandywine Realty Trust is a Philadelphia-based real estate investment trust (REIT) that invests in office buildings in Philadelphia, Washington, D.C., and Austin, Texas.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

IRT vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.4× larger
ORGO
$225.6M
$165.3M
IRT
Growing faster (revenue YoY)
ORGO
ORGO
+75.6% gap
ORGO
78.1%
2.5%
IRT
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
2.2%
IRT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IRT
IRT
ORGO
ORGO
Revenue
$165.3M
$225.6M
Net Profit
$43.7M
Gross Margin
Operating Margin
28.1%
Net Margin
19.4%
Revenue YoY
2.5%
78.1%
Net Profit YoY
469.5%
EPS (diluted)
$0.00
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRT
IRT
ORGO
ORGO
Q1 26
$165.3M
Q4 25
$167.1M
$225.6M
Q3 25
$167.1M
$150.9M
Q2 25
$162.2M
$101.0M
Q1 25
$161.2M
$86.7M
Q4 24
$161.0M
$126.7M
Q3 24
$160.1M
$115.2M
Q2 24
$158.4M
$130.2M
Net Profit
IRT
IRT
ORGO
ORGO
Q1 26
Q4 25
$33.3M
$43.7M
Q3 25
$6.9M
$21.6M
Q2 25
$8.0M
$-9.4M
Q1 25
$8.4M
$-18.8M
Q4 24
$-1.0M
$7.7M
Q3 24
$12.4M
$12.3M
Q2 24
$10.4M
$-17.0M
Gross Margin
IRT
IRT
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
IRT
IRT
ORGO
ORGO
Q1 26
Q4 25
28.1%
Q3 25
13.7%
Q2 25
-12.5%
Q1 25
-30.9%
Q4 24
8.1%
Q3 24
5.4%
Q2 24
-10.7%
Net Margin
IRT
IRT
ORGO
ORGO
Q1 26
Q4 25
19.9%
19.4%
Q3 25
4.1%
14.3%
Q2 25
5.0%
-9.3%
Q1 25
5.2%
-21.7%
Q4 24
-0.6%
6.1%
Q3 24
7.7%
10.7%
Q2 24
6.5%
-13.1%
EPS (diluted)
IRT
IRT
ORGO
ORGO
Q1 26
$0.00
Q4 25
$0.14
$0.31
Q3 25
$0.03
$0.11
Q2 25
$0.03
$-0.10
Q1 25
$0.04
$-0.17
Q4 24
$-0.01
$0.05
Q3 24
$0.05
$0.09
Q2 24
$0.05
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRT
IRT
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$23.3M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.4B
$300.1M
Total Assets
$6.1B
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRT
IRT
ORGO
ORGO
Q1 26
$23.3M
Q4 25
$23.6M
$93.7M
Q3 25
$23.3M
$63.7M
Q2 25
$19.5M
$73.1M
Q1 25
$29.1M
$110.0M
Q4 24
$21.2M
$135.6M
Q3 24
$17.6M
$94.3M
Q2 24
$21.0M
$89.9M
Total Debt
IRT
IRT
ORGO
ORGO
Q1 26
Q4 25
$2.3B
Q3 25
$2.3B
Q2 25
$2.2B
Q1 25
$2.3B
Q4 24
$2.3B
Q3 24
$2.3B
$62.3M
Q2 24
$2.3B
$63.8M
Stockholders' Equity
IRT
IRT
ORGO
ORGO
Q1 26
$3.4B
Q4 25
$3.5B
$300.1M
Q3 25
$3.5B
$255.1M
Q2 25
$3.4B
$233.2M
Q1 25
$3.5B
$242.9M
Q4 24
$3.4B
$262.9M
Q3 24
$3.4B
$278.5M
Q2 24
$3.4B
$263.5M
Total Assets
IRT
IRT
ORGO
ORGO
Q1 26
$6.1B
Q4 25
$6.0B
$598.7M
Q3 25
$6.1B
$509.8M
Q2 25
$6.0B
$461.1M
Q1 25
$6.0B
$467.4M
Q4 24
$6.1B
$497.9M
Q3 24
$5.9B
$446.3M
Q2 24
$5.9B
$443.2M
Debt / Equity
IRT
IRT
ORGO
ORGO
Q1 26
Q4 25
0.66×
Q3 25
0.66×
Q2 25
0.66×
Q1 25
0.65×
Q4 24
0.68×
Q3 24
0.68×
0.22×
Q2 24
0.66×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRT
IRT
ORGO
ORGO
Operating Cash FlowLast quarter
$39.4M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRT
IRT
ORGO
ORGO
Q1 26
Q4 25
$282.1M
$39.4M
Q3 25
$79.3M
$3.1M
Q2 25
$82.2M
$-32.9M
Q1 25
$60.4M
$-19.9M
Q4 24
$259.8M
$10.9M
Q3 24
$69.2M
$8.7M
Q2 24
$83.0M
$4.7M
Free Cash Flow
IRT
IRT
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
IRT
IRT
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
IRT
IRT
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
IRT
IRT
ORGO
ORGO
Q1 26
Q4 25
8.48×
0.90×
Q3 25
11.51×
0.14×
Q2 25
10.22×
Q1 25
7.23×
Q4 24
1.43×
Q3 24
5.60×
0.71×
Q2 24
8.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRT
IRT

Rental and other property revenue$165.2M100%
Other revenue$109.0K0%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons